Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01637870 · ClinicalTrials.gov registry record · NA
Negative Pressure Wound Therapy After Cesarean Delivery
A NA study, sponsored by Abbey Hardy-Fairbanks.
- Completed
- Registry status
- NA
- Development phase
- 110
- Enrollment target
NCT01637870: Completed NA study, sponsored by Abbey Hardy-Fairbanks.
NCT01637870 is a NA study that has completed, run by Abbey Hardy-Fairbanks. The registered enrollment target is 110 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (92% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01637870, a NA study, has completed, sponsored by Abbey Hardy-Fairbanks.
- COMPLETED
- Registry status
- NA
- Development phase
- 110 participants
- Enrollment target
Study Summary
This study is aimed at determining whether or not the use of a wound suction device placed on the cesarean incision instead of a standard sterile dressing will decrease the prevalence of wound complications and wound infections in women at high risk for post operative complications. The study will first look at the infection and wound complication rate in women 6 months prior to the start date of the study by reviewing charts of women who have undergone a cesarean section. The study involves placing a single use, portable wound vacuum over the cesarean section incision and keeping it in place for 72h. The investigators will then compare the rates of wound infection and wound complications between these two groups. It is our hypothesis that negative pressure wound systems will decrease the wound infection and complication rate in this high risk population.
Primary Outcome
Wound infection, separation or deep infection
Interventions
- DEVICE Prevena negative pressure wound system
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 110 participants |
| Start Date | 2012-08 |
| Est. Completion | 2013-02 |
| Phase | NA |
What the finished NCT01637870 record still lists
NCT01637870 is an interventional study that assigns participants to a tested intervention. The registered 110 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (92% lower).
The record links to 0 conditions, and to 1 intervention - of which Prevena negative pressure wound system is the first listed.
NCT01637870 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01637870 about?
NCT01637870 is a clinical study titled "Negative Pressure Wound Therapy After Cesarean Delivery". This study is aimed at determining whether or not the use of a wound suction device placed on the cesarean incision instead of a standard sterile dressing will decrease the prevalence of wound complications and wound infections in women at high risk for post operative complications. The study will f...
What is the current status of trial NCT01637870?
This trial is currently completed. It is a NA study. The enrollment target is 110 participants. The study started on 2012-08. Estimated completion is 2013-02.
What interventions are being tested in trial NCT01637870?
The interventions under investigation include: Prevena negative pressure wound system (DEVICE).
Who is sponsoring clinical trial NCT01637870?
This trial is sponsored by Abbey Hardy-Fairbanks, which has 2 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01637870's enrollment target sits among peer trials
110 816th of 2000 higher than 1,176 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01530373 · 110 participants · Phase 2
Solifenacin Compared to Clonidine for Reducing Hot Flashes Among Breast Cancer Patients
- NCT02379377 · 110 participants · Phase 1
18F-FSPG PET in Imaging Patients With Liver Cancer Before Undergoing Surgery or Transplant
- NCT02411773 · 110 participants · Phase 1
Sympatholysis in Chronic Kidney Disease
- NCT03190941 · 110 participants · Phase 1
Administering Peripheral Blood Lymphocytes Transduced With a Murine T-Cell Receptor Recognizing the G12V Variant of Mutated RAS in HLA-A*11:01 Patients
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia